Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Nesbuvir

SKU: orb1679055

Description

Nesbuvir is a potent and selective inhibitor of the HCV NS5B RNA-dependent RNA polymerase. It demonstrates high antiviral activity in vitro, with an IC50 of 9 nM against HCV genotype 1b replicons in hepatocellular carcinoma cells, supporting its use in hepatitis C virology and antiviral discovery research.

Research Area

Infectious Disease & Virology, Protein Biochemistry

Images & Validation

Key Properties

CAS Number691852-58-1
MW446.49
Purity99.99% (May vary between batches)
FormulaC22H23FN2O5S
SMILESCNC(=O)c1c(oc2cc(N(CCO)S(C)(=O)=O)c(cc12)C1CC1)-c1ccc(F)cc1
TargetHCV Protease
SolubilityDMSO:45 mg/mL (100.79 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.48 mM)

Bioactivity

Target IC50
NS3V170A:13 nM (EC50)|NS3V170A:9 nM (EC50)|NS3K583T:15 nM (EC50)|NS5B:5 nM|NS5BI424V:13 nM (EC50)
In Vivo
Nesbuvir is demonstrated to yield significant antiviral effects in mice with chimeric human livers and in patients infected with HCV. Nesbuvir (chimeric mouse model) treatment resulted in a 2.02 +/- 0.55 log reduction in HCV titer, whereas in combination with interferon using a suboptimal dose of 30 mg/kg three times per day showed a 2.44 log reduction and were better than interferon treatment only.
In Vitro
Nesbuvir (40 or 80 nM) (approximately 10 and 20 times the EC50 in a 3-day replicon inhibition assay, respectively). The EC50 for Nesbuvir in the transient expression assay is 14 nM, whereas it is 5 nM for the stable replicon. Nesbuvir (0.1 and 1 μM; Huh-7 cells; for 16 days) reduced about 3.6 log10 and 4.2 log10 HCV RNA levels, respectively.
Cell Research
Huh7-BB7 cells are seeded at a density of 20,000 cells per 100 mm dish in DMEM supplemented with 2% FBS, 1 mg/mL G418, and various concentrations of Nesbuvir and/or Boceprevir with DMSO at a final concentration of 0.5% (vol/vol). The medium is removed and is replaced with a fresh medium with the appropriate compound concentrations every 3 or 4 days. After 7 days, the cells are split 1 to 10, placed into fresh 100 mm dishes, and incubated with medium with the appropriate compound concentrations. After 20 days, the medium is removed and the cells are fixed with 7% (wt/vol) formaldehyde and stained with 1% (wt/vol) crystal violet in 50% (vol/vol) ethanol .

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Nesbuvir, NS5B polymerase, HCV 796, HCV NS5B polymerase, HCV Protease, HCVProtease, HCV796, HCV-796
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 100.00
2 mg
$ 130.00
5 mg
$ 190.00
1 ml x 10 mM (in DMSO)
$ 200.00
10 mg
$ 240.00
25 mg
$ 380.00
50 mg
$ 540.00
100 mg
$ 690.00
200 mg
$ 910.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry